Currently we know of only a few biomarkers associated with gastric cancer, most notably carcinoembryonic antigen (CEA) and carbohydrate antigen 19–9 (CA 19–9), although their clinical usefulness remains debated due to the low sensitivity and specificity rates [5–7]. The gene discussed is CEACAM5; the disease is gastric cancer.